Deskripsi
Cell viability data from CCK-8 assays performed in triplicate, showing melatonin's dose-dependent inhibition of prostate cancer cell proliferation at 37 degrees Celsius.
Figure 31
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 31: Cell viability data from CCK-8 assays performed in triplicate, showing melatonin's dose-dependent inhibition of prostate cancer cell proliferation at 37 degrees Celsius.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Cell viability data from CCK-8 assays performed in triplicate, showing melatonin's dose-dependent inhibition of prostate cancer cell proliferation at 37 degrees Celsius." /> <figcaption>Figure 31. Cell viability data from CCK-8 assays performed in triplicate, showing melatonin's dose-dependent inhibition of prostate cancer cell proliferation at 37 degrees Celsius.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>